Income Statement Healwell AI Inc.

Equities

AIDX

CA42249X1006

IT Services & Consulting

Market Closed - Toronto S.E. Other stock markets 16:19:36 2024-09-11 EDT			5-day change	1st Jan Change
1.450 ^CAD	-3.97%		-10.49%	+93.33%

09-10	Well Health Completes Acquisition of B.C. Clinics, Provides Update on Canadian Clinics Portfolio	MT
09-10	Well Health Brief: Providing Corporate Update on Canadian Clinics "Reflecting Strong Growth Momentum and Return on Invested Capital (ROIC) Performance"	MT

37c3b0533f8e0ba.zvzkx1BozUt1TRJucE12jFDSphZ_C23OHd5lEaWfaM8.9pqrhDE6-j45H1hXO34c2mKK1V4dehyee5kka9TqC4W-rI2DYVCOHAcSWw

Published financial data: HEALWELL AI INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	46.29M	38.57M	47.82M	53.22M	7.32M
Total Revenues	46.29M	38.57M	47.82M	53.22M	7.32M
Cost of Goods Sold, Total	39.21M	31.48M	32.81M	36.6M	6.06M
Gross Profit	7.08M	7.1M	15.01M	16.62M	1.26M
Selling General & Admin Expenses, Total	5.35M	9.59M	33M	29.43M	14.04M
Provision for Bad Debts	313K	202K	-	-	-
R&D Expenses	-	-	155K	8.14M	4.81M
Depreciation & Amortization - (IS)	3.12M	2.96M	-	-	-
Other Operating Expenses, Total	8.78M	12.75M	33.15M	37.57M	18.85M
Operating Income	-1.7M	-5.65M	-18.14M	-20.95M	-17.59M
Interest Expense, Total	-532K	-501K	-462K	-488K	-1.58M
Interest And Investment Income	76.49K	64K	109K	62K	244K
Net Interest Expenses	-456K	-437K	-353K	-426K	-1.34M
Income (Loss) On Equity Invest.	207K	62K	-	-214K	-
Other Non Operating Income (Expenses)	1.93M	1.72M	-103K	-347K	-420K
EBT, Excl. Unusual Items	-12.08K	-4.31M	-18.6M	-21.94M	-19.35M
Impairment of Goodwill	-	-	-	-	-5.35M
Gain (Loss) On Sale Of Investments	-	-	-	-395K	-2.31M
Gain (Loss) On Sale Of Assets	-16.87K	-	-	-	-
Asset Writedown	-	-	-	-	-5.54M
Insurance Settlements	-	-	674K	936K	774K
Other Unusual Items	-	2.97M	1.64M	1.64M	-900K
EBT, Incl. Unusual Items	-28.95K	-1.34M	-16.29M	-19.75M	-32.68M
Income Tax Expense	91.61K	-312K	-747K	1.22M	-542K
Earnings From Continuing Operations	-121K	-1.03M	-15.54M	-20.97M	-32.14M
Earnings Of Discontinued Operations	-	-	-	-	596K
Net Income to Company	-121K	-1.03M	-15.54M	-20.97M	-31.54M
Minority Interest	287	-2K	-129K	-115K	-52K
Net Income - (IS)	-120K	-1.03M	-15.67M	-21.08M	-31.6M
Net Income to Common Incl Extra Items	-120K	-1.03M	-15.67M	-21.08M	-31.6M
Net Income to Common Excl. Extra Items	-120K	-1.03M	-15.67M	-21.08M	-32.19M
Per Share Items
Net EPS - Basic	-	-0.03	-0.33	-0.42	-0.55
Basic EPS - Continuing Operations	-	-0.03	-0.33	-0.42	-0.56
Basic Weighted Average Shares Outstanding	-	38.33M	48M	50.08M	57.03M
Net EPS - Diluted	-	-0.03	-0.33	-0.42	-0.55
Diluted EPS - Continuing Operations	-	-0.03	-0.33	-0.42	-0.56
Diluted Weighted Average Shares Outstanding	-	38.33M	48M	50.08M	57.03M
Normalized Basic EPS	-	-0.07	-0.24	-0.28	-0.21
Normalized Diluted EPS	-	-0.07	-0.24	-0.28	-0.21
Payout Ratio	-	-195.24	-	-0.55	-
Supplemental Items
EBITDA	-1.15M	-5.18M	-17.05M	-19.47M	-16.11M
EBITA	-1.65M	-5.6M	-17.51M	-19.94M	-16.58M
EBIT	-1.7M	-5.65M	-18.14M	-20.95M	-17.59M
EBITDAR	4.45M	-2.81M	-15.94M	-17.83M	-15.33M
Effective Tax Rate - (Ratio)	-316.45	23.3	4.59	-6.16	1.66
Total Current Taxes	-	121K	47K	265K	19K
Total Deferred Taxes	91.61K	-433K	-794K	952K	-561K
Normalized Net Income	-7.26K	-2.69M	-11.75M	-13.83M	-12.14M
Interest on Long-Term Debt	528K	497K	466K	488K	452K
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	-	1.12M	1.66M	1.28M
General and Administrative Expenses	2.18M	7.22M	18.31M	12.29M	9.06M
Research And Development Expense From Footnotes	-	-	155K	8.14M	4.81M
Net Rental Expense, Total	5.6M	2.37M	1.11M	1.64M	787K
Imputed Operating Lease Interest Expense	1.32M	590K	278K	403K	518K
Imputed Operating Lease Depreciation	4.27M	1.78M	829K	1.24M	269K
Stock-Based Comp., G&A Exp. (Total)	-	-	6.11M	3.01M	2.75M
Stock-Based Comp., Other (Total)	-	751K	-	1.82M	509K
Total Stock-Based Compensation	-	751K	6.11M	4.83M	3.26M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	1.13M	894K	7.14M	1.41M	19.16M
Total Cash And Short Term Investments	1.13M	894K	7.14M	1.41M	19.16M
Accounts Receivable, Total	3.01M	4.02M	6.87M	6.02M	1.24M
Total Receivables	3.01M	4.02M	6.87M	6.02M	1.24M
Prepaid Expenses	-	377K	-	-	-
Other Current Assets, Total	39.33K	489K	2.5M	1.17M	2.35M
Total Current Assets	4.18M	5.78M	16.51M	8.6M	22.76M
Gross Property Plant And Equipment	37.35M	37.78M	38.63M	33.84M	17.3M
Accumulated Depreciation	-21.52M	-24.2M	-24.7M	-23.39M	-13.56M
Net Property Plant And Equipment	15.83M	13.57M	13.93M	10.44M	3.73M
Long-term Investments	-	-	4.54M	3.93M	410K
Goodwill	151K	151K	10.07M	10.07M	12.3M
Other Intangibles, Total	131K	489K	12.45M	11.25M	12.51M
Accounts Receivable Long-Term	1.76M	1.3M	1.44M	860K	249K
Deferred Tax Assets Long-Term	380K	813K	1.56M	152K	-
Other Long-Term Assets, Total	257K	251K	390K	319K	1.74M
Total Assets	22.69M	22.36M	60.89M	45.63M	53.7M
Liabilities
Accounts Payable, Total	2.43M	4.51M	6.55M	5.54M	3.93M
Accrued Expenses, Total	656K	2.23M	2.58M	3.28M	1.98M
Short-term Borrowings	1.25M	1.21M	-	7M	-
Current Portion of Long-Term Debt	96.1K	-	-	-	672K
Current Portion of Leases	2.54M	2.54M	3.09M	1.09M	1.01M
Current Income Taxes Payable	-	126K	177K	230K	19K
Unearned Revenue Current, Total	-	-	282K	438K	335K
Other Current Liabilities	144K	135K	1.82M	1.81M	1.48M
Total Current Liabilities	7.11M	10.74M	14.49M	19.39M	9.42M
Long-Term Debt	-	-	-	-	14.98M
Long-Term Leases	13.31M	11.3M	11.26M	9.33M	4.26M
Deferred Tax Liability Non Current	-	-	2.43M	1.98M	2.02M
Other Non Current Liabilities	-	80K	2.96M	1.44M	1.54M
Total Liabilities	20.43M	22.12M	31.14M	32.14M	32.23M
Common Stock, Total	200	1.01M	39.79M	39.79M	67.37M
Additional Paid In Capital	-	-	4.81M	9.64M	12.57M
Retained Earnings	2.14M	-897K	-16.57M	-37.65M	-69.25M
Comprehensive Income and Other	-	-	-	-	1.96M
Total Common Equity	2.14M	114K	28.03M	11.78M	12.65M
Minority Interest	121K	123K	1.72M	1.72M	8.81M
Total Equity	2.26M	237K	29.75M	13.49M	21.46M
Total Liabilities And Equity	22.69M	22.36M	60.89M	45.63M	53.7M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	46M	50.08M	53.87M	113M
ECS Total Common Shares Outstanding	-	40M	50.08M	50.08M	87.99M
Book Value / Share	-	0	0.56	0.24	0.14
Tangible Book Value	1.86M	-526K	5.5M	-9.55M	-12.16M
Tangible Book Value Per Share	-	-0.01	0.11	-0.19	-0.14
Total Debt	17.2M	15.04M	14.35M	17.42M	20.93M
Net Debt	16.07M	14.15M	7.2M	16.01M	1.77M
Debt Equivalent Oper. Leases	44.79M	18.98M	8.86M	13.1M	6.3M
Minority Interest, Total (Incl. Fin. Div)	121K	123K	1.72M	1.72M	8.81M
Equity Method Investments, Total	-	-	2.52M	2.31M	-
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	6.35M	6.39M	7.05M	6.44M	3.58M
Full Time Employees	340	340	400	400	102
Accumulated Allowance for Doubtful Accounts (Supple)	5.66K	195K	195K	189K	25K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-120K	-1.03M	-15.67M	-21.08M	-31.6M
Depreciation & Amortization - CF	3.07M	2.9M	3.09M	3.22M	1.79M
Amortization of Goodwill and Intangible Assets - (CF)	52.4K	52K	630K	1.01M	1.01M
Depreciation & Amortization, Total	3.12M	2.96M	3.72M	4.23M	2.8M
Amortization of Deferred Charges, Total - (CF)	-	-	585K	1.05M	1.86M
(Gain) Loss From Sale Of Asset	16.87K	-	-	48K	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	395K	2.31M
Asset Writedown & Restructuring Costs	-	-	-	-	10.9M
(Income) Loss On Equity Investments - (CF)	-	-	-	214K	-
Stock-Based Compensation (CF)	-	751K	6.11M	4.83M	3.26M
Provision and Write-off of Bad Debts	313K	202K	696K	63K	11K
Net Cash From Discontinued Operations	-	-	-	-	-2.68M
Other Operating Activities, Total	547K	-388K	-896K	32K	1.28M
Change In Accounts Receivable	-	-1.22M	-1.5M	695K	4.51M
Change In Accounts Payable	-	3.78M	1.11M	-368K	-3.5M
Change in Unearned Revenues	-	-	-	156K	-
Change in Other Net Operating Assets	-664K	-826K	-1.25M	1.4M	52K
Cash from Operations	3.21M	4.22M	-7.1M	-8.35M	-10.8M
Capital Expenditure	-122K	-85K	-833K	-312K	-66K
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-	-5.47M	-	-1.14M
Divestitures	-	-	-	-	2.5M
Sale (Purchase) of Intangible assets	-	-149K	-1.54M	-856K	-
Investment in Marketable and Equity Securities, Total	-	-	-810K	-	-410K
Other Investing Activities, Total	-	-	-	-	473K
Cash from Investing	-122K	-234K	-8.64M	-1.17M	1.35M
Short Term Debt Issued, Total	-	-	-	6.79M	3.27M
Long-Term Debt Issued, Total	449K	536K	498K	604K	168K
Total Debt Issued	449K	536K	498K	7.39M	3.44M
Short Term Debt Repaid, Total	-310K	-43K	-1.92M	-	-1.68M
Long-Term Debt Repaid, Total	-3.03M	-2.71M	-3.2M	-3.49M	-576K
Total Debt Repaid	-3.34M	-2.75M	-5.12M	-3.49M	-2.26M
Issuance of Common Stock	-	-	27.54M	-	17.45M
Repurchase of Common Stock	-	-	-870K	-	-
Common Dividends Paid	-	-2.01M	-	-116K	-
Common & Preferred Stock Dividends Paid	-	-2.01M	-	-116K	-
Other Financing Activities, Total	-	-	-63K	-	8.57M
Cash from Financing	-2.89M	-4.22M	21.99M	3.78M	27.2M
Net Change in Cash	200K	-234K	6.25M	-5.73M	17.75M
Supplemental Items
Levered Free Cash Flow	1.2M	1.57M	-3.65M	-2.39M	-4.1M
Unlevered Free Cash Flow	1.53M	1.88M	-3.36M	-2.08M	-3.11M
Change In Net Working Capital	405K	-1.94M	76K	-2.07M	-37K
Net Debt Issued / Repaid	-2.89M	-2.21M	-4.62M	3.9M	1.18M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-4.43	-15.69	-27.24	-24.58	-22.14
Return on Total Capital	-5.23	-20.34	-38.19	-34.91	-30
Return On Equity %	-5.19	-82.19	-103.67	-96.99	-183.88
Return on Common Equity	-5.46	-91.26	-111.37	-105.95	-263.61
Margin Analysis
Gross Profit Margin %	15.3	18.4	31.39	31.23	17.18
SG&A Margin	11.55	24.87	69.01	55.29	191.85
EBITDA Margin %	-2.48	-13.44	-35.66	-36.58	-220.21
EBITA Margin %	-3.56	-14.52	-36.62	-37.46	-226.62
EBIT Margin %	-3.67	-14.66	-37.94	-39.36	-240.43
Income From Continuing Operations Margin %	-0.26	-2.66	-32.5	-39.4	-439.26
Net Income Margin %	-0.26	-2.67	-32.77	-39.62	-431.83
Net Avail. For Common Margin %	-0.26	-2.67	-32.77	-39.62	-439.98
Normalized Net Income Margin	-0.02	-6.98	-24.58	-25.98	-165.97
Levered Free Cash Flow Margin	2.59	4.06	-7.64	-4.49	-55.99
Unlevered Free Cash Flow Margin	3.31	4.87	-7.03	-3.92	-42.5
Asset Turnover
Asset Turnover	1.93	1.71	1.15	1	0.15
Fixed Assets Turnover	2.77	2.62	3.48	4.37	1.03
Receivables Turnover (Average Receivables)	14.27	10.97	8.78	8.26	2.02
Short Term Liquidity
Current Ratio	0.59	0.54	1.14	0.44	2.42
Quick Ratio	0.58	0.46	0.97	0.38	2.17
Operating Cash Flow to Current Liabilities	0.45	0.39	-0.49	-0.43	-1.15
Days Sales Outstanding (Average Receivables)	25.58	33.36	41.56	44.2	181.1
Average Days Payable Outstanding	23.66	40.3	61.5	60.29	285.37
Long Term Solvency
Total Debt/Equity	760.39	6.35K	48.23	129.09	97.5
Total Debt / Total Capital	88.38	98.45	32.54	56.35	49.37
LT Debt/Equity	588.57	4.77K	37.86	69.17	89.67
Long-Term Debt / Total Capital	68.41	73.94	25.54	30.19	45.4
Total Liabilities / Total Assets	90.03	98.94	51.15	70.43	60.03
EBIT / Interest Expense	-3.19	-11.29	-39.27	-42.93	-11.14
EBITDA / Interest Expense	2.67	-5.39	-31.21	-34.27	-9.37
(EBITDA - Capex) / Interest Expense	2.44	-5.56	-33.01	-34.91	-9.41
Total Debt / EBITDA	12.1	-5.57	-1	-1.04	-1.41
Net Debt / EBITDA	11.3	-5.24	-0.5	-0.96	-0.12
Total Debt / (EBITDA - Capex)	13.23	-5.4	-0.94	-1.02	-1.41
Net Debt / (EBITDA - Capex)	12.36	-5.08	-0.47	-0.94	-0.12
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.73	-16.67	23.96	11.3	-29.81
Gross Profit, 1 Yr. Growth %	2.19	0.21	16.15	10.72	-66.12
EBITDA, 1 Yr. Growth %	-7.43	352.27	392.69	14.16	-3.66
EBITA, 1 Yr. Growth %	-4.14	240.55	351.31	13.86	-3.58
EBIT, 1 Yr. Growth %	-4.01	233.18	361.37	15.48	-3.39
Earnings From Cont. Operations, 1 Yr. Growth %	-50.2	748.76	1.41K	34.93	76.65
Net Income, 1 Yr. Growth %	-47.51	743.44	1.42K	34.56	49.86
Normalized Net Income, 1 Yr. Growth %	-93.88	29.42K	321.68	17.64	0.98
Diluted EPS Before Extra, 1 Yr. Growth %	-	736.23	1.12K	28.98	54.38
Accounts Receivable, 1 Yr. Growth %	-13.19	33.31	70.98	-12.37	-79.39
Net Property, Plant and Equip., 1 Yr. Growth %	-9.83	-14.26	2.65	-25.04	-64.25
Total Assets, 1 Yr. Growth %	-10.11	-1.44	172.34	-25.06	17.68